by Absci
Origin-1 is a generative AI platform for the de novo design of therapeutic antibodies targeting 'zero-prior' epitopes—sites with no previously known structural data or existing treatments
Complete information about the vendor/provider of this AI application
Legal, privacy, and compliance documentation
Get insights into risk by running assessments on this AI application.
Types of data commonly processed by this application
Discover EU-based alternatives for this AI application.
Track, assess, and govern your AI applications with Anove.
